Hindustan Unilever Limited is an India-based consumer goods company. With over 35 brands spanning 20 distinct categories such as soaps, detergents, shampoos, skin care, toothpastes, deodorants, cosmetics, tea, coffee, packaged foods, ice cream, and water purifiers, the Company is a part of the everyday life of millions of consumers across India. Its portfolio includes leading household brands such as Lux, Lifebuoy, Surf Excel, Rin, Wheel, Fair & Lovely, Pond’s, Vaseline, Lakmé, Dove, Clinic Plus, Sunsilk, Pepsodent, Closeup, Axe, Brooke Bond, Bru, Knorr, Kissan, Kwality Wall’s and Pureit.

stock-detail

SHORT TERM PERSPECTIVE

Company Hindustan Unilever Ltd.
Recommendation Buy (Rs.2057.35)
CMP Rs.2057.35
Stop Loss (SL) Rs.1960
Target Price Rs.2140-Rs.2300
Time Horizon 2-4 Weeks

Stock-Graph

Intermediate and long term trend is up in this stock, after correction stock has developed short term base near to 200 EMA and formed higher top higher bottom formation which is a bullish pattern in nature. Technically stock is trading with bullish channel. A bullish RSI and MACD buy signal has emerged on the Daily chart. Increasing in volume and positive diversion from oscillator indicate that stock can move higher from current level so one can initiate a buy position at CMP Rs. 2057.35 with a stop loss of Rs. 1960 on (closing basis) for the  target price of Rs. 2140 – Rs. 2300. Time frame should be 2-4 weeks.

DISCLOSURE IN PURSUANCE OF SECTION 19 OF SEBI (RA) REGULATION 2014

Elite Wealth Advisors Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Advisors Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as read more


For Daily Share Market Updates, Daily debt market review, Market Research Analysis reports, Weekly Techno-Funda Report, Fundamental Analysis Report, Monthly Recommended stock Picks, Equity Trading Tips, Upcoming IPO/NFO/Bonds/Ncd’s updates & other related information Subscribe our research plan